Business Context and Reporting Period
Company: Organigram Global Inc.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: February 2026
Date Filed: February 20, 2026
Principal Executive Offices: Toronto, Ontario, Canada
This filing serves as a current report disclosing material corporate events rather than a periodic financial statement. The registrant files annual reports under Form 40-F.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a disclosure of specific contractual agreements and does not contain financial performance data for the period.
Material Changes and Corporate Actions
The filing discloses the execution of two significant agreements dated February 18, 2026, submitted as exhibits:
- Exhibit 99.1: Share Sale and Purchase Agreement regarding shares in Sanity Group GmbH.
- Exhibit 99.2: Subscription Agreement between BT DE Investments Inc. and Organigram Global Inc.
Certain portions of these exhibits have been redacted as they are considered private or confidential, though the registrant agrees to provide unredacted copies to the SEC upon request.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for management guidance, future outlook, specific risk factors, or contingencies beyond the disclosure of the aforementioned agreements. No unusual items or management commentary regarding financial performance are included in this specific report.
Investor Verification Checklist
- Verify the terms and valuation of the Share Sale and Purchase Agreement with Sanity Group GmbH (Exhibit 99.1).
- Review the capital raise details and terms within the Subscription Agreement with BT DE Investments Inc. (Exhibit 99.2).
- Confirm the extent of redacted information in the exhibits to assess potential materiality.
- Check subsequent filings for the financial impact of these transactions on the company's balance sheet and cash position.